Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
- PMID: 40102406
- PMCID: PMC11920101
- DOI: 10.1038/s41537-025-00595-0
Author Correction: Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
Erratum for
-
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials.Schizophrenia (Heidelb). 2024 Nov 2;10(1):102. doi: 10.1038/s41537-024-00525-6. Schizophrenia (Heidelb). 2024. PMID: 39488504 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
